IPS supports 50,000 sqft sterile injectable expansion

Published: 22-Nov-2021

The EPCMV specialist has provided complete design and engineering services for the high-speed filling line

IPS-Integrated Project Services, a provider of engineering, procurement, construction management, and validation (EPCMV) services, has supported pharmaceutical contract manufacturer Jubilant HollisterStier's site master planning efforts to expand the company's Spokane site's capacity.

IPS provided complete design and engineering services for the 50,000 sqft expansion that will house a high-speed filling line and lyophilisers, increasing the facility's sterile injectable capacity by 50%.

"Based on our trajectory analysis of the sterile injectable market, as well as ongoing conversations with existing partners, there is need to add capacity at our existing facility," said Amit Arora, President, Jubilant HollisterStier. "The pandemic has fortified our commitment to being ready to quickly support the innovative pharmaceutical partners we work with, whose drugs play an instrumental role in saving the lives of many."

"Continuous improvements and growth are at the core of our values at Jubilant. That is why we are very pleased to make this investment of US$92Mn approx. in a state-of-the-art filling machine that features the highest degree of quality and compliance to meet current regulatory standards and service our customer's need even better" added Pramod Yadav, CEO of parent company Jubilant Pharma.

The new filling line will be commercially available by the end of 2024. Jubilant HollisterStier has already begun filling the 200+ new roles created to support this expansion and is actively recruiting at this time.

"As the proven leader in designing, building, and validating advanced aseptic processing facilities with barrier technology, IPS couldn't be prouder to support this project," said Mark Butler, IPS' President and Managing Director - Americas.

You may also like